Lack of prothrombin gene mutation in young stroke patients

R. A. Egan, J. M. Kuyl, Richard Press, Helmi Lutsep

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There is an increased incidence of hematologic abnormalities in young stroke patients. The prothrombin gene G20210A mutation (PGM) is a newly described risk factor found in association with clotting disorders. Currently, a clear association of PGM with arterial stroke has not been described. This article examines the frequency of PGM in a consecutive series of young stroke patients. All patients who were 55 years of age or younger who were admitted to the Oregon Health Sciences University for arterial stroke between December 1, 1997 and August 31, 1998 were examined for the PGM. Plasma was analyzed at the Medical Genetics Center at Oregon Health Sciences University. We identified 42 young stroke patients with a mean age of 43 (range, 19 to 55); 48% were women. Thirty-eight patients had plasma tested for PGM. The cause of stroke in 6 patients (14%) was believed to be secondary to atherosclerosis, 4 (10%) had strokes caused by cardioembolism, 9 (21%) were lacunar, 5 (12%) were secondary to dissection, and 12 (28%) were idiopathic. No patient in the study carried the PGM. The defined frequency of PGM in our laboratory in the healthy population is 2.05%. We found no association of PGM with stroke in the 38 patients studied. PGM does not appear to be a risk factor for arterial stroke in this high-risk population. However, the small sample size warrants further study.

Original languageEnglish (US)
Pages (from-to)229-231
Number of pages3
JournalJournal of Stroke and Cerebrovascular Diseases
Volume9
Issue number5
DOIs
StatePublished - 2000

Fingerprint

Prothrombin
Stroke
Mutation
Genes
Gene Frequency
Health
Medical Genetics
Sample Size
Population
Dissection
Atherosclerosis
Incidence

Keywords

  • Hypercoagulable
  • Prothrombin gene mutation
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Health Professions(all)

Cite this

Lack of prothrombin gene mutation in young stroke patients. / Egan, R. A.; Kuyl, J. M.; Press, Richard; Lutsep, Helmi.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 9, No. 5, 2000, p. 229-231.

Research output: Contribution to journalArticle

@article{80d27a2b82664db5b26cc774df467be0,
title = "Lack of prothrombin gene mutation in young stroke patients",
abstract = "There is an increased incidence of hematologic abnormalities in young stroke patients. The prothrombin gene G20210A mutation (PGM) is a newly described risk factor found in association with clotting disorders. Currently, a clear association of PGM with arterial stroke has not been described. This article examines the frequency of PGM in a consecutive series of young stroke patients. All patients who were 55 years of age or younger who were admitted to the Oregon Health Sciences University for arterial stroke between December 1, 1997 and August 31, 1998 were examined for the PGM. Plasma was analyzed at the Medical Genetics Center at Oregon Health Sciences University. We identified 42 young stroke patients with a mean age of 43 (range, 19 to 55); 48{\%} were women. Thirty-eight patients had plasma tested for PGM. The cause of stroke in 6 patients (14{\%}) was believed to be secondary to atherosclerosis, 4 (10{\%}) had strokes caused by cardioembolism, 9 (21{\%}) were lacunar, 5 (12{\%}) were secondary to dissection, and 12 (28{\%}) were idiopathic. No patient in the study carried the PGM. The defined frequency of PGM in our laboratory in the healthy population is 2.05{\%}. We found no association of PGM with stroke in the 38 patients studied. PGM does not appear to be a risk factor for arterial stroke in this high-risk population. However, the small sample size warrants further study.",
keywords = "Hypercoagulable, Prothrombin gene mutation, Stroke",
author = "Egan, {R. A.} and Kuyl, {J. M.} and Richard Press and Helmi Lutsep",
year = "2000",
doi = "10.1053/jscd.2000.6187",
language = "English (US)",
volume = "9",
pages = "229--231",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Lack of prothrombin gene mutation in young stroke patients

AU - Egan, R. A.

AU - Kuyl, J. M.

AU - Press, Richard

AU - Lutsep, Helmi

PY - 2000

Y1 - 2000

N2 - There is an increased incidence of hematologic abnormalities in young stroke patients. The prothrombin gene G20210A mutation (PGM) is a newly described risk factor found in association with clotting disorders. Currently, a clear association of PGM with arterial stroke has not been described. This article examines the frequency of PGM in a consecutive series of young stroke patients. All patients who were 55 years of age or younger who were admitted to the Oregon Health Sciences University for arterial stroke between December 1, 1997 and August 31, 1998 were examined for the PGM. Plasma was analyzed at the Medical Genetics Center at Oregon Health Sciences University. We identified 42 young stroke patients with a mean age of 43 (range, 19 to 55); 48% were women. Thirty-eight patients had plasma tested for PGM. The cause of stroke in 6 patients (14%) was believed to be secondary to atherosclerosis, 4 (10%) had strokes caused by cardioembolism, 9 (21%) were lacunar, 5 (12%) were secondary to dissection, and 12 (28%) were idiopathic. No patient in the study carried the PGM. The defined frequency of PGM in our laboratory in the healthy population is 2.05%. We found no association of PGM with stroke in the 38 patients studied. PGM does not appear to be a risk factor for arterial stroke in this high-risk population. However, the small sample size warrants further study.

AB - There is an increased incidence of hematologic abnormalities in young stroke patients. The prothrombin gene G20210A mutation (PGM) is a newly described risk factor found in association with clotting disorders. Currently, a clear association of PGM with arterial stroke has not been described. This article examines the frequency of PGM in a consecutive series of young stroke patients. All patients who were 55 years of age or younger who were admitted to the Oregon Health Sciences University for arterial stroke between December 1, 1997 and August 31, 1998 were examined for the PGM. Plasma was analyzed at the Medical Genetics Center at Oregon Health Sciences University. We identified 42 young stroke patients with a mean age of 43 (range, 19 to 55); 48% were women. Thirty-eight patients had plasma tested for PGM. The cause of stroke in 6 patients (14%) was believed to be secondary to atherosclerosis, 4 (10%) had strokes caused by cardioembolism, 9 (21%) were lacunar, 5 (12%) were secondary to dissection, and 12 (28%) were idiopathic. No patient in the study carried the PGM. The defined frequency of PGM in our laboratory in the healthy population is 2.05%. We found no association of PGM with stroke in the 38 patients studied. PGM does not appear to be a risk factor for arterial stroke in this high-risk population. However, the small sample size warrants further study.

KW - Hypercoagulable

KW - Prothrombin gene mutation

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0034502693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034502693&partnerID=8YFLogxK

U2 - 10.1053/jscd.2000.6187

DO - 10.1053/jscd.2000.6187

M3 - Article

VL - 9

SP - 229

EP - 231

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 5

ER -